Physician profile
Michael H Rehal
NPI 1487926507
$1,495.86
in general payments reported to CMS, 2019-2025
34 companies · $370 in 2025
The $370 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82.49 · 2022: $392 · 2023: $387 · 2024: $265 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,021.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $368.13 | 2022-2025 | Restrata Wound Matrix |
| Kerecis Limited | $135.71 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Stryker Corporation | $114.26 | 2024-2025 | Motionsense Digital Goniometer, Mako |
| Integra Lifesciences Corporation | $87.36 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Onkos Surgical, INC. | $84.34 | 2023 | Eleos Limb Salvage System |
| Incyte Corporation | $55.66 | 2021-2023 | Jakafi |
| Becton, Dickinson and Company | $44.94 | 2024 | Channel Drain |
| Amgen INC. | $44.80 | 2021-2023 | Lumakras |
| Daiichi Sankyo INC. | $43.77 | 2021-2023 | Enhertu |
| Kci USA, INC. | $39.67 | 2023 | Prevena, Activ.A.C. Ion Progress, Snap |
| Urgo Medical North America, LLC | $35.01 | 2025 | Urgok2 |
| Astrazeneca Pharmaceuticals LP | $34.98 | 2022 | |
| Genmab U.S., INC. | $30.44 | 2022 | |
| Ucb, INC. | $28.00 | 2023 | |
| Servier Pharmaceuticals LLC | $25.88 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $25.86 | 2024 | Physio-Stim |
| Tactile Systems Technology INC | $25.47 | 2024 | Flexitouch Plus, Entre Plus |
| My01 INC. | $24.67 | 2024 | My01 Continuous Compartmental Pressure Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $23.65 | 2022 | |
| Ethicon US, LLC | $22.50 | 2025 | Surgicel Nu-Knit, Evarrest, Vistaseal |
| Depuy Synthes Sales INC. | $18.65 | 2023 | Na |
| Solventum Corporation | $16.47 | 2025 | Prevena |
| Lilly USA, LLC | $16.29 | 2022 | |
| Genentech USA, INC. | $15.00 | 2023 | Rozlytrek, Tecentriq |
| Taiho Oncology, INC. | $14.75 | 2022 | |
| Merck Sharp & Dohme LLC | $14.07 | 2021 | |
| Duchesnay USA Incorporated | $14.05 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $14.00 | 2025 | |
| Glaxosmithkline, LLC. | $13.97 | 2024 | Ojjaara |
| Janssen Biotech, INC. | $13.86 | 2022 | |
| Pfizer INC. | $13.09 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $12.71 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.68 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $11.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rehal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.